New York (CBS News) – The FDA has approved the marketing of the first medical device to treat ADHD in children. The system will be available by prescription to kids ages 7 to 12 years old who do not currently take prescribed medication for the disorder. It works by delivering a low-level electrical pulse into the nervous system through a patch on a child’s forehead. Previous studies have shown the device increases activity in parts of the brain that are important in regulating attention, emotion and behavior.
A new study from Harvard finds 81% of popular e-cigarette cartridges and refillable liquids contain fungal toxins. 27% contain traces of bacterial toxins. Scientists say exposure to these microbial contaminants are associated with asthma, reduced lung function and inflammation.
And some people may be more genetically prone to cannabis addiction according to a new study. London researchers focused on three genetic markers. One of them is associated with people continuing to want more cannabis after having just used it.
Those are some of today’s top health stories.
Kenneth Craig, CBS News, New York.